Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Aug;51(8):1001–1004. doi: 10.1136/ard.51.8.1001

Recovery from pulmonary hypertension in an adolescent with mixed connective tissue disease.

D M Friedman 1, H J Mitnick 1, D Danilowicz 1
PMCID: PMC1004814  PMID: 1417105

Abstract

This paper describes the case of an 11 year old girl who presented with mixed connective tissue disease which was complicated by the development of pulmonary hypertension. This case is unique with respect to the young age of onset, the serial non-invasive method used to follow the disease process, and the favourable response to treatment with vasodilator and anti-inflammatory drugs.

Full text

PDF
1001

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson R. A., Mackworth-Young C. G., Boey M. L., Hull R. G., Saunders A., Gharavi A. E., Hughes G. R. Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) 1983 Oct 8;287(6398):1024–1025. doi: 10.1136/bmj.287.6398.1024-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bush A., Busst C., Booth K., Knight W. B., Shinebourne E. A. Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease? Circulation. 1986 Jul;74(1):135–144. doi: 10.1161/01.cir.74.1.135. [DOI] [PubMed] [Google Scholar]
  3. Cohen M., Edwards W. D., Fuster V. Regression in thromboembolic type of primary pulmonary hypertension during 2 1/2 years of antithrombotic therapy. J Am Coll Cardiol. 1986 Jan;7(1):172–175. doi: 10.1016/s0735-1097(86)80277-7. [DOI] [PubMed] [Google Scholar]
  4. Comens S. M., Alpert M. A., Sharp G. C., Pressly T. A., Kelly D. L., Hazelwood S. E., Mukerji V. Frequency of mitral valve prolapse in systemic lupus erythematosus, progressive systemic sclerosis and mixed connective tissue disease. Am J Cardiol. 1989 Feb 1;63(5):369–370. doi: 10.1016/0002-9149(89)90351-2. [DOI] [PubMed] [Google Scholar]
  5. Fuster V., Steele P. M., Edwards W. D., Gersh B. J., McGoon M. D., Frye R. L. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation. 1984 Oct;70(4):580–587. doi: 10.1161/01.cir.70.4.580. [DOI] [PubMed] [Google Scholar]
  6. Jones M. B., Osterholm R. K., Wilson R. B., Martin F. H., Commers J. R., Bachmayer J. D. Fatal pulmonary hypertension and resolving immune-complex glomerulonephritis in mixed connective tissue disease. A case report and review of the literature. Am J Med. 1978 Nov;65(5):855–863. doi: 10.1016/0002-9343(78)90806-9. [DOI] [PubMed] [Google Scholar]
  7. King M. E., Braun H., Goldblatt A., Liberthson R., Weyman A. E. Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. Circulation. 1983 Jul;68(1):68–75. doi: 10.1161/01.cir.68.1.68. [DOI] [PubMed] [Google Scholar]
  8. Kitabatake A., Inoue M., Asao M., Masuyama T., Tanouchi J., Morita T., Mishima M., Uematsu M., Shimazu T., Hori M. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation. 1983 Aug;68(2):302–309. doi: 10.1161/01.cir.68.2.302. [DOI] [PubMed] [Google Scholar]
  9. Kosturakis D., Goldberg S. J., Allen H. D., Loeber C. Doppler echocardiographic prediction of pulmonary arterial hypertension in congenital heart disease. Am J Cardiol. 1984 Apr 1;53(8):1110–1115. doi: 10.1016/0002-9149(84)90646-5. [DOI] [PubMed] [Google Scholar]
  10. Packer M., Medina N., Yushak M. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease. J Am Coll Cardiol. 1984 Nov;4(5):890–901. doi: 10.1016/s0735-1097(84)80048-0. [DOI] [PubMed] [Google Scholar]
  11. Perkin R. M., Anas N. G. Pulmonary hypertension in pediatric patients. J Pediatr. 1984 Oct;105(4):511–522. doi: 10.1016/s0022-3476(84)80413-8. [DOI] [PubMed] [Google Scholar]
  12. Rich S., Brundage B. H., Levy P. S. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Circulation. 1985 Jun;71(6):1191–1196. doi: 10.1161/01.cir.71.6.1191. [DOI] [PubMed] [Google Scholar]
  13. Rich S., Kieras K., Hart K., Groves B. M., Stobo J. D., Brundage B. H. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol. 1986 Dec;8(6):1307–1311. doi: 10.1016/s0735-1097(86)80301-1. [DOI] [PubMed] [Google Scholar]
  14. Rubin L. J., Peter R. H. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med. 1980 Jan 10;302(2):69–73. doi: 10.1056/NEJM198001103020201. [DOI] [PubMed] [Google Scholar]
  15. Ryan T., Petrovic O., Dillon J. C., Feigenbaum H., Conley M. J., Armstrong W. F. An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol. 1985 Apr;5(4):918–927. doi: 10.1016/s0735-1097(85)80433-2. [DOI] [PubMed] [Google Scholar]
  16. Singsen B. H., Bernstein B. H., Kornreich H. K., King K. K., Hanson V., Tan E. M. Mixed connective tissue disease in childhood. A clinical and serologic survey. J Pediatr. 1977 Jun;90(6):893–900. doi: 10.1016/s0022-3476(77)80555-6. [DOI] [PubMed] [Google Scholar]
  17. Sullivan W. D., Hurst D. J., Harmon C. E., Esther J. H., Agia G. A., Maltby J. D., Lillard S. B., Held C. N., Wolfe J. F., Sunderrajan E. V. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984 Mar;63(2):92–107. doi: 10.1097/00005792-198403000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES